Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
21.20
+0.25 (1.19%)
At close: Aug 1, 2025, 4:00 PM
21.21
+0.01 (0.05%)
After-hours: Aug 1, 2025, 4:20 PM EDT
Chimerix Stock Forecast
Stock Price Forecast
The 4 analysts that cover Chimerix stock have a consensus rating of "Hold" and an average price target of $38, which forecasts a 79.25% increase in the stock price over the next year. The lowest target is $30 and the highest is $55.
Price Target: $38.00 (+79.25%)
Analyst Consensus: Hold
* Price targets were last updated on May 12, 2025.
Analyst Ratings
The average analyst rating for Chimerix stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 1 | 1 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 3 | 3 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy → Hold Downgrades $45 → $30 | Buy → Hold | Downgrades | $45 → $30 | +41.51% | May 12, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $40 → $35 | Buy | Maintains | $40 → $35 | +65.09% | May 8, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 10, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $36 → $32 | Hold | Maintains | $36 → $32 | +50.94% | Mar 21, 2025 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $66 → $36 | Buy → Hold | Downgrades | $66 → $36 | +69.81% | Feb 4, 2025 |
Financial Forecast
Revenue This Year
738.70M
from 731.97M
Increased by 0.92%
Revenue Next Year
779.69M
from 738.70M
Increased by 5.55%
EPS This Year
3.21
from 3.06
Increased by 4.80%
EPS Next Year
3.64
from 3.21
Increased by 13.63%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 767.6M | 843.2M | 882.3M | ||
| Avg | 738.7M | 779.7M | 806.0M | ||
| Low | 704.2M | 711.5M | 716.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.9% | 14.1% | 13.2% | ||
| Avg | 0.9% | 5.5% | 3.4% | ||
| Low | -3.8% | -3.7% | -8.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.60 | 3.83 | 4.04 | ||
| Avg | 3.21 | 3.64 | 3.91 | ||
| Low | 2.99 | 3.38 | 3.73 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 17.7% | 19.4% | 11.0% | ||
| Avg | 4.8% | 13.6% | 7.3% | ||
| Low | -2.3% | 5.4% | 2.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.